Hepatitis B virus X protein promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating SOCS1
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Hepatocellular carcinoma (HCC), a primary type of liver cancer, is one of the leading causes of cancer related deaths worldwide. HCC patients have poor prognosis due to intrahepatic and extrahepatic metastasis. Hepatitis B virus (HBV) infection is one of the major causes of various liver diseases including HCC. Among HBV gene products, HBV X protein (HBx) plays an important role in the development and metastasis of HCC. However, the mechanism of HCC metastasis induced by HBx has not been elucidated yet. In this study, for the first time, we report that HBx interacts with the suppressor of cytokine signaling 1 (SOCS1) which negatively controls NF-κB by degrading p65, a subunit of NF-κB. NF-κB activates the transcription of factors associated with epithelial-mesenchymal transition (EMT), a crucial cellular process associated with invasiveness and migration of cancer cells. Here, we report that HBx physically binds to SOCS1, subsequently prevents the ubiquitination of p65, activates the transcription of EMT transcription factors and enhance cell migration and invasiveness, suggesting a new mechanism of HBV-associated HCC metastasis.
Abstract
Hepatocellular carcinoma (HCC), a primary type of liver cancer, is one of the leading causes of cancer related deaths worldwide. HCC patients have poor prognosis due to intrahepatic and extrahepatic metastasis. Hepatitis B virus (HBV) infection is one of the major causes of various liver diseases including HCC. Among HBV gene products, HBV X protein (HBx) plays an important role in the development and metastasis of HCC. However, the mechanism of HCC metastasis induced by HBx has not been elucidated yet. In this study, for the first time, we report that HBx interacts with the suppressor of cytokine signaling 1 (SOCS1) which negatively controls NF-κB by degrading p65, a subunit of NF-κB. NF-κB activates the transcription of factors associated with epithelial-mesenchymal transition (EMT), a crucial cellular process associated with invasiveness and migration of cancer cells. Here, we report that HBx physically binds to SOCS1, subsequently prevents the ubiquitination of p65, activates the transcription of EMT transcription factors and enhance cell migration and invasiveness, suggesting a new mechanism of HBV-associated HCC metastasis.
참고문헌 (35)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Petrick JL, "International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007", Int J Cancer, 139, pp.1534~1545 (2016)
- Zamor PJ, "Viral hepatitis and hepatocellular carcinoma : etiology and management", J Gastrointest Oncol, 8, pp.229~242 (2017)
- Liu CJ, "Hepatitis B virus-related hepatocellular carcinoma : epidemiology and pathogenic role of viral factors", J Chin Med Assoc, 70, pp.141~145 (2007)
- Zhang X, "Effects of hepatitis B virus X protein on the development of liver cancer", J Lab Clin Med, 147, pp.58~66 (2006)
- Yuan H, "HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver", Theranostics, 11, pp.8362~8378 (2021)
- Cheng ST, "HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis", Biochem Biophys Res Commun, 496, pp.904~910 (2018)
- Zhang C, "C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway", Microb Pathog, 159, pp.105136~ (2021)
- Kim HR, "The hepatitis B viral X protein activates NF-kappa B signaling pathway through the up-regulation of TBK1", FEBS Lett, 584, pp.525~530 (2010)
- Zha Y, "Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2", Oncol Lett, 16, pp.5709~5714 (2018)
- Yang SZ, "HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro", Dig Liver Dis, 53, pp.360~366 (2021)
- Cano A, "The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression", Nat Cell Biol, 2, pp.76~83 (2000)
- Peinado H, "Snail, Zeb and bHLH factors in tumour progression : an alliance against the epithelial phenotype?", Nat Rev Cancer, 7, pp.415~428 (2007)
- Pires BRB, "NF-kappaB is involved in the regulation of emt genes in breast cancer cells", PLoS One, 12, pp.e0169622~ (2017)
- Zhong ZM, "Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-kappaB pathway", Cell Physiol Biochem, 24, pp.105~114 (2009)
- Hayden MS, "NF-kappaB in immunobiology", Cell Res, 21, pp.223~244 (2011)
- Maier HJ, "NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells", Cancer Lett, 295, pp.214~228 (2010)
- Ko E, "CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma", Cancer Lett, 271, pp.240~250 (2008)
- Croker BA, "SOCS regulation of the JAK", STAT signalling pathway, 2008, pp.19, 414~422
- Gui YR, "SOCS1controls liver regeneration by regulating HGF signaling in hepatocytes", J Hepatol, 55, pp.1300~1308 (2011)
- Ryo A, "Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65", RelA, 2003, pp.12, 1413~1426
- Zhang JJ, "Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment", Cell Mol Immunol, 11, pp.396~404 (2014)
- Yoshida T, "SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis", J Exp Med, 199, pp.1701~1707 (2004)
- Gui YR, "Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1", World J Gastroenterol, 23, pp.6639~6649 (2017)
- Kim JY, "HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1-and NFkappaB-dependent pathways", J Mol Biol, 397, pp.917~931 (2010)
- Liu LP, "The role of NFkappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs", Cancer Invest, 28, pp.443~451 (2010)
- Liau NPD, "The molecular basis of JAK", STAT inhibition by SOCS1, 2018, pp.9, 1558~
- Um TH, "Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis", J Hepatol, 54, pp.939~947 (2011)
- Zhang X, "An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma", J Viral Hepat, 21, pp.264~271 (2014)
- Strebovsky J, "Suppressor of cytokine signaling 1(SOCS1)limits NFκB signaling by decreasing p65 stability within the cell nucleus", FASEB J, 25, pp.863~874 (2011)
- Wang F, "Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma", Mol Cancer, 14, pp.1~14 (2015)
- Kile BT, "The SOCS box : a tale of destruction and degradation", Trends Biochem Sci, 27, pp.235~241 (2002)
- Willems AR, "A hitchhiker’s guide to the cullin ubiquitin ligases : SCF and its kin", Biochim Biophys Acta, 1695, pp.133~170 (2004)
- Maine GN, "COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase", EMBO J, 26, pp.436~447 (2007)
- Kim SY, "Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression", IUBMB Life, 57, pp.651~658 (2005)
